Ledger.Open graph →
SEC Form D · filed June 1, 2018

Quellis Biosciences, Inc

Offering
Sold
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHILADELPHIA, PA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Tomas Kiselak · Philadelphia, PAExec · DirectorPeter Harwin · Philadelphia, PAExec · DirectorFred Callori · Philadelphia, PADirectorStephen M. Wagman · Boca Raton, FLExec · DirectorDavid H. Treitel · Boca Raton, FLExec · DirectorChris Garabedian · Delanson, NYDirectorDebora M. Covell · Wyomissing, KYExec · DirectorJames C. Waldinger · New York, NYExec · DirectorChris Garabedian · Delanson, NYDirectorFred Callori · Philadelphia, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗